Free Trial
→ We recommended Palantir in 2021, now we’re recommending this... (From Behind the Markets) (Ad) Free CRSP Stock Alerts

CRISPR Therapeutics (CRSP) SEC Filings & 10K Form

CRISPR Therapeutics logo
$41.59 -0.45 (-1.07%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$41.68 +0.09 (+0.22%)
As of 01/31/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent CRISPR Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/10/2025
8:23 PM		ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
12/27/2024
4:35 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
12:34 PM		ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:35 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
8:05 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
8:10 AM		CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
4:35 PM		CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM		CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM		Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
5:00 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
5:00 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:22 PM		CRISPR Therapeutics (Filer)
Form S-3ASR
06/24/2024
4:35 PM		Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
7:06 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:50 PM		Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:50 PM		CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
7:14 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:15 PM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:24 PM		CRISPR Therapeutics (Subject)
Kulkarni Samarth (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
10:58 AM		Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
04/09/2024
3:42 PM		CRISPR Therapeutics (Filer)
Form DEF 14A
04/09/2024
3:43 PM		CRISPR Therapeutics (Filer)
Form DEFA14A
04/09/2024
3:47 PM		CRISPR Therapeutics (Filer)
Form ARS
03/27/2024
3:30 PM		CRISPR Therapeutics (Filer)
Form PRE 14A
03/27/2024
3:30 PM		CRISPR Therapeutics (Filer)
Form PRE 14A
03/22/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:45 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:02 PM		CRISPR Therapeutics (Subject)
Morrow Phuong Khanh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:43 PM		CRISPR Therapeutics (Subject)
Kulkarni Samarth (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:45 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:39 PM		CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:45 PM		CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>
02/21/2024
6:45 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
6:50 AM		CRISPR Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
4:45 PM		CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:30 PM		CRISPR Therapeutics (Subject)
Kulkarni Samarth (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
4:22 PM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:44 AM		CRISPR Therapeutics (Filer)
Form 424B5
02/13/2024
5:30 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
5:30 AM		CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
5:22 PM		CRISPR Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
02/05/2024
5:08 AM		CRISPR Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CRSP) was last updated on 2/2/2025 by MarketBeat.com Staff
From Our Partners
Stunning Trump Manhattan Project Now Underway
Just as I predicted, President Trump announced his #1 move during his first 100 days... His allies are call...
Banyan Hill Publishing | Sponsored
Trump’s New AI Move Could Trigger Massive Melt UP
In his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....
InvestorPlace | Sponsored
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Texas approves new currency
Rural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...
Stansberry Research | Sponsored
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Elon Social Security shock?
“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...
Altimetry | Sponsored
This Crypto Is Set to Explode in January
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Will DeepSeek pop the AI bubble?
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored